An Analysis of Accelrys
Imran Mohiuddin
Pharmacopeia Inc.


Offers products and services enabling
drug and chemical discovery.
Accelrys is the software development
division of Pharmacopeia Inc.
Basic Information




Accelrys was developed in the 1980s,
apparently an international effort.
Claims to have ~600 employees worldwide.
50% of staff are Ph.D. scientists specializing
in disciplines across chemistry, biology, and
materials research.
complemented by employees educated in
software and systems engineering and
project management.
Basic Information




Main Headquarters in San Diego.
Also maintain “Centers of Excellence”
in Cambridge, UK and Bangalore,
India.
Publicly traded on NASDAQ (ACCL).
Reported a 2003 revenue of $86
million.
Accelrys?


The company specializes in providing
software for research and
development in pharmaceuticals,
biotechnology, and chemicals.
In addition to its biotechnology
customer base, Accelrys also serves a
wide range of other trades, including
the automotive, aerospace,
electronics, and energy industries.
Discovery Studio


Chemistry multi-tool to aid in drug
development.
“Complete range of life science
applications spanning scientific
disciplines within a single unified
platform. Enables scientists to capture,
manage, analyze, and use biological
and chemical data and information
within an integrated system.”
Materials Studio


Advanced materials simulation and
informatics.
“Dramatically enhances your ability to
mine, analyze, present, and
communicate data and information
relating to chemicals and materials.“
Informatics



Bioinformatics - manage, organize,
apply biological/genome information.
Cheminformatics - manage, organize,
apply chemical information.
Matinformatics - manage, organize,
apply information related to materials.
Modeling, Simulation, and Analysis



Molecular Graphics - Use 3D modeling
to understand chemical structure
Statistical. Correlations - Analyze data
to build statistical models that explain
and predict properties.
Atomistic Simulation - Predict the
behavior of chemical and biological
systems .
Modeling, Simulation, and Analysis



Quantum Mechanics - Accurate prediction of
chemical properties and reactivity.
Mesoscale Modeling - Predict key processes
in complex fluids and soft materials.
Structure Characterization - Characterize
molecular structure, often based on data
from analytical instruments.
Customers






Academic Institutions
Government Labs
Pharmaceutical corporations (DuPont)
Biotechnology companies
(Genaissance)
Chemical companies (Dow)
Other industries, including automotive,
aerospace, electronics, and energy.
Strategic Business
Aliances






IBM
HP
Sun Microsystems
Oracle
Intel
More
Executives

CEO - Mark J. Emkjer
– CEO Mark J. Emkjer, was previously President
and Chief Operating Officer of Sunquest
Information Systems, Inc., a $150 million
information technology business that develops
laboratory, radiology and pharmacy systems.
Prior to joining Sunquest, he was President and
Chief Executive Officer of Pace Health
Management Systems, Inc., a provider of clinical
decision support software.
Executives

CFO - John J. Hanlon
– John J. Hanlon was President and CFO of
a publicly held e-payment service
provider. He also spent 10 years as CFO
of MDL Information Systems, Inc., a
provider of integrated scientific
information management systems,
databases and services, and an additional
10 years in public accounting at Coopers
and Lybrand.
Executives

HOT - Dr. Scott Kahn
– Received his Ph.D. in Theoretical Organic
Chemistry from the University of
California, Irvine, after which he did postdoctoral work at Cambridge University,
UK. Dr. Kahn is an experienced software
developer and created analysis tools for
medicinal chemistry research and
modeling.
Will It Work?
Will it Work?

Net Income
–
–
–
–
2000
2001
2002
2003
-
$1175
$14,320
$11,627
$3,497